
Role of Chromogenic FVIII Assays in Hemophilia A Diagnosis
In the Tuesday afternoon session entitled Role of Chromogenic Assays in Hemophilia Diagnosis, Elizabeth Duncan presented a comparison of clotting
Year: 2023
Language: English
Author(s): World Federation of Hemophilia
Format: Document
This fact sheet contains commonly asked questions and more information on hemostatic rebalancing therapy.
Learn more about different treatment options for hemophilia with the World Federation of Hemophilia Shared Decision Making tool!
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

In the Tuesday afternoon session entitled Role of Chromogenic Assays in Hemophilia Diagnosis, Elizabeth Duncan presented a comparison of clotting

The purpose of this guide is to inform and facilitate the selection and purchase of therapeutic products for the treatment

Adapted from: Global NMO Training 2016 plenary presentation by Glenn PierceReviewed by: Glenn PierceEdited by: Georghia Michael This first eLearning

A summary of discussions held at the Tenth WFH Global Forum on Research and Treatment Products for Bleeding Disorders which

Using the universal language of pictures, children around the world can learn about hemophilia in a fun, easy to understand,

This illustrated schematic demonstrates the normal process of blood clotting, how it is diminished when a clotting factor is lacking,